Group Therapy Using the "I-Reconstruction" Psychotherapy Method to Reduce Anxiety Levels

Summary

Brief Summary of the Study The aim of this clinical trial is to find out if the group therapy method "Self-Reconstruction" helps to reduce anxiety in adults. The researchers want to see if the participants' emotional state becomes more stable after completing the course. The main questions that this study aims to answer are: Do people's anxiety levels decrease after taking the course of "I-Reconstruction" classes? Do the positive effects of the classes persist 3, 6 and 12 months after they finish? Do the participants' quality of life and ability to enjoy life improve? The researchers will compare a group of people who attend the therapy classes with a group of people who receive usual care to see if the new method is more effective. Participants will: Participate in 10 online group meetings once a week. Do simple breathing and movement exercises to calm the body and emotions. Discuss your feelings and desires with a professional in a safe group. Complete questionnaires about your condition at the beginning, during, and after the study.

Eligibility

Inclusion Criteria:

Age between 18 and 55 years (inclusive).

Clinically significant level of anxiety according to the Beck Anxiety Inventory (BAI) ≥ 9 points.

Anxiety subscale score on the Hospital Anxiety and Depression Scale (HADS-A) ≥ 11 points.

Significant level of preverbal trauma according to the "Diagnostics of Preverbal Dysregulation" (DPD, T. Pavlenko) questionnaire: total score ≥ 16.

Specific subscale scores in DPD: "Desire" ≥ 5, "Satisfaction" ≥ 5, and "Possession" (Obsession) ≥ 6 points.

Presence of internal conflicts according to the "Internal Conflict Test" (ICT) ≥ 1 point on the skin tissue measurement scale.

Willingness to comply with the study protocol and the online therapy format.

Exclusion Criteria:

Current participation in any other psychotherapy during the study.

Use of any psychotropic medications within the last 30 days (antidepressants, tranquilizers, neuroleptics, mood stabilizers).

Diagnosed severe mental disorders (according to ICD-10/DSM-5) requiring specialized psychiatric care or inpatient treatment.

Presence of acute suicidal risk.

Substance abuse (alcoholism, drug addiction).

Failure to meet any of the threshold values specified in the inclusion criteria.

Conditions3

Browse More Trials